Global Antisense and RNAi Therapeutics Market Insights and Forecast to 2028
Table of Contents1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antisense and RNAi Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 RNA Interference
1.2.3 Antisense RNA
1.3 Market by Application
1.3.1 Global Antisense and RNAi Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Antisense and RNAi Therapeutics Market Perspective (2017-2028)
2.2 Antisense and RNAi Therapeutics Growth Trends by Region
2.2.1 Antisense and RNAi Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Antisense and RNAi Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Antisense and RNAi Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Antisense and RNAi Therapeutics Market Dynamics
2.3.1 Antisense and RNAi Therapeutics Industry Trends
2.3.2 Antisense and RNAi Therapeutics Market Drivers
2.3.3 Antisense and RNAi Therapeutics Market Challenges
2.3.4 Antisense and RNAi Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antisense and RNAi Therapeutics Players by Revenue
3.1.1 Global Top Antisense and RNAi Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Antisense and RNAi Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Antisense and RNAi Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antisense and RNAi Therapeutics Revenue
3.4 Global Antisense and RNAi Therapeutics Market Concentration Ratio
3.4.1 Global Antisense and RNAi Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antisense and RNAi Therapeutics Revenue in 2021
3.5 Antisense and RNAi Therapeutics Key Players Head office and Area Served
3.6 Key Players Antisense and RNAi Therapeutics Product Solution and Service
3.7 Date of Enter into Antisense and RNAi Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antisense and RNAi Therapeutics Breakdown Data by Type
4.1 Global Antisense and RNAi Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Antisense and RNAi Therapeutics Forecasted Market Size by Type (2023-2028)
5 Antisense and RNAi Therapeutics Breakdown Data by Application
5.1 Global Antisense and RNAi Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Antisense and RNAi Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Antisense and RNAi Therapeutics Market Size (2017-2028)
6.2 North America Antisense and RNAi Therapeutics Market Size by Type
6.2.1 North America Antisense and RNAi Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Antisense and RNAi Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Antisense and RNAi Therapeutics Market Share by Type (2017-2028)
6.3 North America Antisense and RNAi Therapeutics Market Size by Application
6.3.1 North America Antisense and RNAi Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Antisense and RNAi Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Antisense and RNAi Therapeutics Market Share by Application (2017-2028)
6.4 North America Antisense and RNAi Therapeutics Market Size by Country
6.4.1 North America Antisense and RNAi Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Antisense and RNAi Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Antisense and RNAi Therapeutics Market Size (2017-2028)
7.2 Europe Antisense and RNAi Therapeutics Market Size by Type
7.2.1 Europe Antisense and RNAi Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Antisense and RNAi Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Antisense and RNAi Therapeutics Market Share by Type (2017-2028)
7.3 Europe Antisense and RNAi Therapeutics Market Size by Application
7.3.1 Europe Antisense and RNAi Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Antisense and RNAi Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Antisense and RNAi Therapeutics Market Share by Application (2017-2028)
7.4 Europe Antisense and RNAi Therapeutics Market Size by Country
7.4.1 Europe Antisense and RNAi Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Antisense and RNAi Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antisense and RNAi Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Antisense and RNAi Therapeutics Market Size by Type
8.2.1 Asia-Pacific Antisense and RNAi Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Antisense and RNAi Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Antisense and RNAi Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Antisense and RNAi Therapeutics Market Size by Application
8.3.1 Asia-Pacific Antisense and RNAi Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Antisense and RNAi Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Antisense and RNAi Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Antisense and RNAi Therapeutics Market Size by Region
8.4.1 Asia-Pacific Antisense and RNAi Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Antisense and RNAi Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Antisense and RNAi Therapeutics Market Size (2017-2028)
9.2 Latin America Antisense and RNAi Therapeutics Market Size by Type
9.2.1 Latin America Antisense and RNAi Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Antisense and RNAi Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Antisense and RNAi Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Antisense and RNAi Therapeutics Market Size by Application
9.3.1 Latin America Antisense and RNAi Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Antisense and RNAi Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Antisense and RNAi Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Antisense and RNAi Therapeutics Market Size by Country
9.4.1 Latin America Antisense and RNAi Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Antisense and RNAi Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antisense and RNAi Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Antisense and RNAi Therapeutics Market Size by Type
10.2.1 Middle East & Africa Antisense and RNAi Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Antisense and RNAi Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Antisense and RNAi Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Antisense and RNAi Therapeutics Market Size by Application
10.3.1 Middle East & Africa Antisense and RNAi Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Antisense and RNAi Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Antisense and RNAi Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Antisense and RNAi Therapeutics Market Size by Country
10.4.1 Middle East & Africa Antisense and RNAi Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Antisense and RNAi Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Tekmira Pharmaceuticals
11.1.1 Tekmira Pharmaceuticals Company Details
11.1.2 Tekmira Pharmaceuticals Business Overview
11.1.3 Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Introduction
11.1.4 Tekmira Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Business (2017-2022)
11.1.5 Tekmira Pharmaceuticals Recent Developments
11.2 Arbutus Biopharma
11.2.1 Arbutus Biopharma Company Details
11.2.2 Arbutus Biopharma Business Overview
11.2.3 Arbutus Biopharma Antisense and RNAi Therapeutics Introduction
11.2.4 Arbutus Biopharma Revenue in Antisense and RNAi Therapeutics Business (2017-2022)
11.2.5 Arbutus Biopharma Recent Developments
11.3 Alnylam Pharmaceuticals
11.3.1 Alnylam Pharmaceuticals Company Details
11.3.2 Alnylam Pharmaceuticals Business Overview
11.3.3 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Introduction
11.3.4 Alnylam Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Business (2017-2022)
11.3.5 Alnylam Pharmaceuticals Recent Developments
11.4 Antisense Therapeutics
11.4.1 Antisense Therapeutics Company Details
11.4.2 Antisense Therapeutics Business Overview
11.4.3 Antisense Therapeutics Antisense and RNAi Therapeutics Introduction
11.4.4 Antisense Therapeutics Revenue in Antisense and RNAi Therapeutics Business (2017-2022)
11.4.5 Antisense Therapeutics Recent Developments
11.5 Silence Therapeutics
11.5.1 Silence Therapeutics Company Details
11.5.2 Silence Therapeutics Business Overview
11.5.3 Silence Therapeutics Antisense and RNAi Therapeutics Introduction
11.5.4 Silence Therapeutics Revenue in Antisense and RNAi Therapeutics Business (2017-2022)
11.5.5 Silence Therapeutics Recent Developments
11.6 Isis Pharmaceuticals
11.6.1 Isis Pharmaceuticals Company Details
11.6.2 Isis Pharmaceuticals Business Overview
11.6.3 Isis Pharmaceuticals Antisense and RNAi Therapeutics Introduction
11.6.4 Isis Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Business (2017-2022)
11.6.5 Isis Pharmaceuticals Recent Developments
11.7 Sirnaomics
11.7.1 Sirnaomics Company Details
11.7.2 Sirnaomics Business Overview
11.7.3 Sirnaomics Antisense and RNAi Therapeutics Introduction
11.7.4 Sirnaomics Revenue in Antisense and RNAi Therapeutics Business (2017-2022)
11.7.5 Sirnaomics Recent Developments
11.8 Santaris
11.8.1 Santaris Company Details
11.8.2 Santaris Business Overview
11.8.3 Santaris Antisense and RNAi Therapeutics Introduction
11.8.4 Santaris Revenue in Antisense and RNAi Therapeutics Business (2017-2022)
11.8.5 Santaris Recent Developments
11.9 Roche
11.9.1 Roche Company Details
11.9.2 Roche Business Overview
11.9.3 Roche Antisense and RNAi Therapeutics Introduction
11.9.4 Roche Revenue in Antisense and RNAi Therapeutics Business (2017-2022)
11.9.5 Roche Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of TablesTable 1. Global Antisense and RNAi Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of RNA Interference
Table 3. Key Players of Antisense RNA
Table 4. Global Antisense and RNAi Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Antisense and RNAi Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Antisense and RNAi Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Antisense and RNAi Therapeutics Market Share by Region (2017-2022)
Table 8. Global Antisense and RNAi Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Antisense and RNAi Therapeutics Market Share by Region (2023-2028)
Table 10. Antisense and RNAi Therapeutics Market Trends
Table 11. Antisense and RNAi Therapeutics Market Drivers
Table 12. Antisense and RNAi Therapeutics Market Challenges
Table 13. Antisense and RNAi Therapeutics Market Restraints
Table 14. Global Antisense and RNAi Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Antisense and RNAi Therapeutics Revenue Share by Players (2017-2022)
Table 16. Global Top Antisense and RNAi Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense and RNAi Therapeutics as of 2021)
Table 17. Ranking of Global Top Antisense and RNAi Therapeutics Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Antisense and RNAi Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Antisense and RNAi Therapeutics Product Solution and Service
Table 21. Date of Enter into Antisense and RNAi Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Antisense and RNAi Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Antisense and RNAi Therapeutics Revenue Market Share by Type (2017-2022)
Table 25. Global Antisense and RNAi Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Antisense and RNAi Therapeutics Revenue Market Share by Type (2023-2028)
Table 27. Global Antisense and RNAi Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Antisense and RNAi Therapeutics Revenue Share by Application (2017-2022)
Table 29. Global Antisense and RNAi Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Antisense and RNAi Therapeutics Revenue Share by Application (2023-2028)
Table 31. North America Antisense and RNAi Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Antisense and RNAi Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Antisense and RNAi Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Antisense and RNAi Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Antisense and RNAi Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Antisense and RNAi Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Antisense and RNAi Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Antisense and RNAi Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Antisense and RNAi Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Antisense and RNAi Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Antisense and RNAi Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Antisense and RNAi Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Antisense and RNAi Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Antisense and RNAi Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Antisense and RNAi Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Antisense and RNAi Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Antisense and RNAi Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Antisense and RNAi Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Antisense and RNAi Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Antisense and RNAi Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Antisense and RNAi Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Antisense and RNAi Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Antisense and RNAi Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Antisense and RNAi Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Antisense and RNAi Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Antisense and RNAi Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Antisense and RNAi Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Antisense and RNAi Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Antisense and RNAi Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Antisense and RNAi Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 61. Tekmira Pharmaceuticals Company Details
Table 62. Tekmira Pharmaceuticals Business Overview
Table 63. Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Product
Table 64. Tekmira Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Business (2017-2022) & (US$ Million)
Table 65. Tekmira Pharmaceuticals Recent Developments
Table 66. Arbutus Biopharma Company Details
Table 67. Arbutus Biopharma Business Overview
Table 68. Arbutus Biopharma Antisense and RNAi Therapeutics Product
Table 69. Arbutus Biopharma Revenue in Antisense and RNAi Therapeutics Business (2017-2022) & (US$ Million)
Table 70. Arbutus Biopharma Recent Developments
Table 71. Alnylam Pharmaceuticals Company Details
Table 72. Alnylam Pharmaceuticals Business Overview
Table 73. Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Product
Table 74. Alnylam Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Business (2017-2022) & (US$ Million)
Table 75. Alnylam Pharmaceuticals Recent Developments
Table 76. Antisense Therapeutics Company Details
Table 77. Antisense Therapeutics Business Overview
Table 78. Antisense Therapeutics Antisense and RNAi Therapeutics Product
Table 79. Antisense Therapeutics Revenue in Antisense and RNAi Therapeutics Business (2017-2022) & (US$ Million)
Table 80. Antisense Therapeutics Recent Developments
Table 81. Silence Therapeutics Company Details
Table 82. Silence Therapeutics Business Overview
Table 83. Silence Therapeutics Antisense and RNAi Therapeutics Product
Table 84. Silence Therapeutics Revenue in Antisense and RNAi Therapeutics Business (2017-2022) & (US$ Million)
Table 85. Silence Therapeutics Recent Developments
Table 86. Isis Pharmaceuticals Company Details
Table 87. Isis Pharmaceuticals Business Overview
Table 88. Isis Pharmaceuticals Antisense and RNAi Therapeutics Product
Table 89. Isis Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Business (2017-2022) & (US$ Million)
Table 90. Isis Pharmaceuticals Recent Developments
Table 91. Sirnaomics Company Details
Table 92. Sirnaomics Business Overview
Table 93. Sirnaomics Antisense and RNAi Therapeutics Product
Table 94. Sirnaomics Revenue in Antisense and RNAi Therapeutics Business (2017-2022) & (US$ Million)
Table 95. Sirnaomics Recent Developments
Table 96. Santaris Company Details
Table 97. Santaris Business Overview
Table 98. Santaris Antisense and RNAi Therapeutics Product
Table 99. Santaris Revenue in Antisense and RNAi Therapeutics Business (2017-2022) & (US$ Million)
Table 100. Santaris Recent Developments
Table 101. Roche Company Details
Table 102. Roche Business Overview
Table 103. Roche Antisense and RNAi Therapeutics Product
Table 104. Roche Revenue in Antisense and RNAi Therapeutics Business (2017-2022) & (US$ Million)
Table 105. Roche Recent Developments
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Antisense and RNAi Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. RNA Interference Features
Figure 3. Antisense RNA Features
Figure 4. Global Antisense and RNAi Therapeutics Market Share by Application: 2021 VS 2028
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Antisense and RNAi Therapeutics Report Years Considered
Figure 8. Global Antisense and RNAi Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Antisense and RNAi Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Antisense and RNAi Therapeutics Market Share by Region: 2021 VS 2028
Figure 11. Global Antisense and RNAi Therapeutics Market Share by Players in 2021
Figure 12. Global Top Antisense and RNAi Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense and RNAi Therapeutics as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Antisense and RNAi Therapeutics Revenue in 2021
Figure 14. North America Antisense and RNAi Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 15. North America Antisense and RNAi Therapeutics Market Size Market Share by Type (2017-2028)
Figure 16. North America Antisense and RNAi Therapeutics Market Size Market Share by Application (2017-2028)
Figure 17. North America Antisense and RNAi Therapeutics Market Size Share by Country (2017-2028)
Figure 18. United States Antisense and RNAi Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Antisense and RNAi Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Antisense and RNAi Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 21. Europe Antisense and RNAi Therapeutics Market Size Market Share by Type (2017-2028)
Figure 22. Europe Antisense and RNAi Therapeutics Market Size Market Share by Application (2017-2028)
Figure 23. Europe Antisense and RNAi Therapeutics Market Size Share by Country (2017-2028)
Figure 24. Germany Antisense and RNAi Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Antisense and RNAi Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Antisense and RNAi Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Antisense and RNAi Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Antisense and RNAi Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Antisense and RNAi Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Antisense and RNAi Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 31. Asia Pacific Antisense and RNAi Therapeutics Market Size Market Share by Type (2017-2028)
Figure 32. Asia Pacific Antisense and RNAi Therapeutics Market Size Market Share by Application (2017-2028)
Figure 33. Asia Pacific Antisense and RNAi Therapeutics Market Size Share by Region (2017-2028)
Figure 34. China Antisense and RNAi Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Antisense and RNAi Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Antisense and RNAi Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Antisense and RNAi Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Antisense and RNAi Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Antisense and RNAi Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
List of FiguresFigure 40. Latin America Antisense and RNAi Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 41. Latin America Antisense and RNAi Therapeutics Market Size Market Share by Type (2017-2028)
Figure 42. Latin America Antisense and RNAi Therapeutics Market Size Market Share by Application (2017-2028)
Figure 43. Latin America Antisense and RNAi Therapeutics Market Size Share by Country (2017-2028)
Figure 44. Mexico Antisense and RNAi Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Brazil Antisense and RNAi Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa Antisense and RNAi Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Middle East and Africa Antisense and RNAi Therapeutics Market Size Market Share by Type (2017-2028)
Figure 48. Middle East and Africa Antisense and RNAi Therapeutics Market Size Market Share by Application (2017-2028)
Figure 49. Middle East and Africa Antisense and RNAi Therapeutics Market Size Share by Country (2017-2028)
Figure 50. Turkey Antisense and RNAi Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Antisense and RNAi Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. UAE Antisense and RNAi Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Tekmira Pharmaceuticals Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2017-2022)
Figure 54. Arbutus Biopharma Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2017-2022)
Figure 55. Alnylam Pharmaceuticals Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2017-2022)
Figure 56. Antisense Therapeutics Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2017-2022)
Figure 57. Silence Therapeutics Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2017-2022)
Figure 58. Isis Pharmaceuticals Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2017-2022)
Figure 59. Sirnaomics Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2017-2022)
Figure 60. Santaris Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2017-2022)
Figure 61. Roche Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2017-2022)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed